ABCC7 p.Thr1036Ile
ClinVar: |
c.3107C>A
,
p.Thr1036Asn
?
, not provided
|
CF databases: |
c.3107C>T
,
p.Thr1036Ile
(CFTR1)
D
, He is from the Qazvin province, located between the centre and north-west of Iran.
|
Predicted by SNAP2: | A: D (63%), C: D (66%), D: D (75%), E: D (80%), F: D (80%), G: D (75%), H: D (71%), I: D (75%), K: D (71%), L: D (80%), M: D (66%), N: D (66%), P: D (75%), Q: D (71%), R: D (71%), S: N (53%), V: D (75%), W: D (85%), Y: D (80%), |
Predicted by PROVEAN: | A: D, C: D, D: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, V: D, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Analysis of the CFTR gene in Iranian cystic fibros... J Cyst Fibros. 2008 Mar;7(2):102-9. Epub 2007 Jul 27. Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
J Cyst Fibros. 2008 Mar;7(2):102-9. Epub 2007 Jul 27., [PMID:17662673]
Abstract [show]
BACKGROUND: Cystic fibrosis (CF) is the most common inherited disorder in Caucasian populations, with over 1400 mutations identified in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene. Mutations in the CFTR gene may be also causative for CBAVD (Congenital Bilateral Absence of the Vas Deferens). The type and distribution of mutations varies widely between different countries and/or ethnic groups, and is relatively unknown in Iran. We therefore performed a comprehensive analysis of the CFTR gene in Iranian CF patients. METHODS: 69 Iranian CF patients, and 1 CBAVD patient, were analysed for mutations in the complete coding region, and its exon/intron junctions, of their CFTR genes, using different methods, such as ARMS (amplification refractory mutation system)-PCR, SSCP (single stranded conformation polymorphism) analysis, restriction enzyme digestion analysis, direct sequencing, and MLPA (Multiplex Ligation-mediated Probe Amplification). RESULTS: CFTR mutation analysis revealed the identification of 37 mutations in 69 Iranian CF patients. Overall, 81.9% (113/138) CFTR genes derived from Iranian CF patients could be characterized for a disease-causing mutation. The CBAVD patient was found to be homozygous for the p.W1145R mutation. The most common mutations were p.F508del (DeltaF508) (18.1%), c.2183_2184delAAinsG (2183AA>G) (6.5%), p.S466X (5.8%), p.N1303K (4.3%), c.2789+5G>A (4.3%), p.G542X (3.6%), c.3120+1G>A (3.6%), p.R334W (2.9%) and c.3130delA (2.9%). These 9 types of mutant CFTR genes totaled for 52% of all CFTR genes derived from the 69 Iranian CF patients. Eight mutations, c.406-8T>C, p.A566D, c.2576delA, c.2752-1_2756delGGTGGCinsTTG, p.T1036I, p.W1145R, c.3850-24G>A, c.1342-?_1524+?del, were found for the first time in this study. CONCLUSIONS: We identified 37 CFTR mutations in 69 well characterized Iranian CF patients, obtaining a CFTR mutation detection rate of 81.9%, the highest detection rate obtained in the Iranian population so far. These findings will assist in genetic counseling, prenatal diagnosis and future screening of CF in Iran.
Comments [show]
None has been submitted yet.
No. Sentence Comment
10 Eight mutations, c.406-8TNC, p.A566D, c.2576delA, c.2752-1_2756delGGTGGCinsTTG, p.T1036I, p.W1145R, c.3850-24GNA, c.1342-?_1524+?del, were found for the first time in this study.
X
ABCC7 p.Thr1036Ile 17662673:10:82
status: NEW14 Keywords: Cystic fibrosis; CFTR; Mutations; Iran; Direct sequencing; c.2576delA; p.A566D; c.2752-1_2756delGGTGGCinsTTG; p.T1036I; p.W1145R; CFTRdele9; c.406-8TNC; c.3850-24GNA 1.
X
ABCC7 p.Thr1036Ile 17662673:14:122
status: NEW37 1 c.406-3TNC I3 T to C at 406-3 mRNA splicing defect 1 p.R170H E5 G to A at 641 Arg to His at 170 1 p.D192G E5 A to G at 707 Asp to Gly at 192 2 p.R334W E7 C to T at 1132 Arg to Trp at 334 4 c.1525-1GNA I9 G to A at 1525-1 mRNA splicing defect 2 p.F508del E10 Deletion of CTT from 1653 Deletion of Phe at 508 25 p.S466X E10 C to G at 1529 Ser to stop at 466 8 c.1677delTA E10 Deletion of TA from 1677 Frame shift 2 p.G542X E11 G to T at 1756 Gly to stop at 542 5 p.S549R E11 T to G at 1779 Ser to Arg at 549 2 p.A566D E12 C to A at 1829 Ala to Asp at 566 2 c.1898+1GNT I12 G→T at 1898+1 mRNA splicing defect 2 c.2183_2184delAAinsG E13 A to G at 2183 and deletion of A at 2184 Frame shift 9 c.2576delA E13 Deletion of A at 2576 Frame shift 1 c.2043delG E13 Deletion of A at 2043 Frame shift 1 c.2184insA E13 Insertion of A after 2184 Frame shift 1 p.R785X E13 C to T at 2485 Arg to stop at 785 2 c.2752-1_2756delGGTGGCinsTTG I14a/ Deletion of GGTGGC mRNA splicing defect 2 E14b From 2752-1 to 2756 and insertion TTG c.2789+5GNA I14b G to A at 2789+5 mRNA splicing defect 6 p.S945L E15 C to Tat 2966 Ser to Leu at 945 2 c.3120+1GNA I16 G to A at 3120+1 mRNA splicing defect 5 c.3121-1GNA I16 G to A at 3121-1 mRNA splicing defect 2 c.3130delA E17a Deletion of A at 3130 Frame shift 4 p.T1036I E17a C to T at 3239 Thr to Ile at 1036 1 p.R1066C E17b C to T at 3328 Arg to Cys at 1066 1 p.L1077P E17b T to C at 3362 Leu to Pro at 1077 1 p.T1086I E17b C to T at 3389 Thr to Ile at 1086 1 p.R1162X E19 C to T at 3616 Arg to stop at 1162 2 p.K1177X E19 A to T at 3361 Lys to stop at 1177 2 c.3850-24GNA I19 G to A at 3850-24 mRNA splicing defect?
X
ABCC7 p.Thr1036Ile 17662673:37:1290
status: NEWX
ABCC7 p.Thr1036Ile 17662673:37:1291
status: NEW66 Results A total of 69 unrelated CF patients (38 male and 31 female; aged between 2 months and 15 years) of Iranian Table 2 Genotype of CFTR genes in 53 Iranian patients Genotype Exon/intron Number of patients p.F508del/p.F508del E10/E10 10 p.F508del/p.R1162X E10/E19 2 p.F508del/p.T1036I E10/E17a 1 p.F508del/p.R1066C E10/E17b 1 p.F508del/c.1342-?_1524+?del E10/E9 1 p.S466X/p.S466X E10/E10 4 c.2183_2184delAAinsG/ c.2183_2184delAAinsG E13/E13 4 c.2183_2184delAAinsG/c.186- ?_296+?del E13/E2 1 p.N1303K/p.N1303K E21/E21 2 p.N1303K/p.S945L E21/E15 1 p.N1303K/c.1677delTA E21/E10 1 p.G542X/p.G542X E11/E11 2 p.G542X/c.2789+5GNA E11/I14b 1 c.3120+1GNA/c.3120+1GNA I16/I16 2 c.3120+1GNA/c.3121-1GNA I16 1 c.3121-1GNA/p.T1086I I16/E17b 1 c.3130delA/c.3130delA E17a/E17a 2 p.D192G/p.D192G E5/E5 1 p.R334W/p.R334W E7/E7 1 p.R334W/p.S945L E7/E15 1 p.R334W/p.L1077P E7/E17b 1 c.1525-1GNA/c.1525-1GNA I9/I9 1 p.S549R/p.S549R E11/E11 1 p.A566D/p.A566D E12/E12 1 c.1898+1GNT/c.1898+1GNT I12/I12 1 c.2576delA/p.S1455X/ E13/E24 1 c.2184insA/c.1677delTA E10/E13 1 p.R785X/p.R785X E13/E13 1 c.2752-1_2756delGGTGGCinsTTG/ c.2752-1_2756delGGTGGCinsTTG I14a/E14b 1 c.2789+5GNA/c.2789+5GNA I14b/I14b 1 p.K1177X/p.K1177X E19/E19 1 c.406-?_1716+?del/c.406-?_1716+?del E4-E10/E4-E10 1 Total 53 origin were extensively studied for the presence of mutations in the CFTR gene, for the presence of the deep intronic 3849+10 kbC→T mutation, and large deletions/ duplications.
X
ABCC7 p.Thr1036Ile 17662673:66:281
status: NEW106 The p.T1036I missense mutation is located in exon 17a, and was found in one patient who carried p.F508del in compound heterozygosity.
X
ABCC7 p.Thr1036Ile 17662673:106:6
status: NEW65 Results A total of 69 unrelated CF patients (38 male and 31 female; aged between 2 months and 15 years) of Iranian Table 2 Genotype of CFTR genes in 53 Iranian patients Genotype Exon/intron Number of patients p.F508del/p.F508del E10/E10 10 p.F508del/p.R1162X E10/E19 2 p.F508del/p.T1036I E10/E17a 1 p.F508del/p.R1066C E10/E17b 1 p.F508del/c.1342-?_1524+?del E10/E9 1 p.S466X/p.S466X E10/E10 4 c.2183_2184delAAinsG/ c.2183_2184delAAinsG E13/E13 4 c.2183_2184delAAinsG/c.186- ?_296+?del E13/E2 1 p.N1303K/p.N1303K E21/E21 2 p.N1303K/p.S945L E21/E15 1 p.N1303K/c.1677delTA E21/E10 1 p.G542X/p.G542X E11/E11 2 p.G542X/c.2789+5GNA E11/I14b 1 c.3120+1GNA/c.3120+1GNA I16/I16 2 c.3120+1GNA/c.3121-1GNA I16 1 c.3121-1GNA/p.T1086I I16/E17b 1 c.3130delA/c.3130delA E17a/E17a 2 p.D192G/p.D192G E5/E5 1 p.R334W/p.R334W E7/E7 1 p.R334W/p.S945L E7/E15 1 p.R334W/p.L1077P E7/E17b 1 c.1525-1GNA/c.1525-1GNA I9/I9 1 p.S549R/p.S549R E11/E11 1 p.A566D/p.A566D E12/E12 1 c.1898+1GNT/c.1898+1GNT I12/I12 1 c.2576delA/p.S1455X/ E13/E24 1 c.2184insA/c.1677delTA E10/E13 1 p.R785X/p.R785X E13/E13 1 c.2752-1_2756delGGTGGCinsTTG/ c.2752-1_2756delGGTGGCinsTTG I14a/E14b 1 c.2789+5GNA/c.2789+5GNA I14b/I14b 1 p.K1177X/p.K1177X E19/E19 1 c.406-?_1716+?del/c.406-?_1716+?del E4-E10/E4-E10 1 Total 53 origin were extensively studied for the presence of mutations in the CFTR gene, for the presence of the deep intronic 3849+10 kbCT mutation, and large deletions/ duplications.
X
ABCC7 p.Thr1036Ile 17662673:65:281
status: NEW105 The p.T1036I missense mutation is located in exon 17a, and was found in one patient who carried p.F508del in compound heterozygosity.
X
ABCC7 p.Thr1036Ile 17662673:105:6
status: NEW[hide] Mutation Analysis of Exons 10 and 17a of CFTR Gene... J Reprod Infertil. 2014 Jan;15(1):49-56. Sahami A, Alibakhshi R, Ghadiri K, Sadeghi H
Mutation Analysis of Exons 10 and 17a of CFTR Gene in Patients with Cystic Fibrosis in Kermanshah Province, Western Iran.
J Reprod Infertil. 2014 Jan;15(1):49-56., [PMID:24696795]
Abstract [show]
BACKGROUND: Cystic fibrosis (CF) is the most common genetic disorder with autosomal recessive inheritance among Caucasian populations. So far, more than 1950 different mutations were identified in cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR gene has 27 exons. The type and distribution of mutations vary widely among different countries and/or ethnic groups. Therefore, a comprehensive analysis was performed on exon10 and exon17a of CFTR gene in CF patients in the Kermanshah province, western Iran. METHODS: We tested 27 patients admitted to the medical genetics laboratory of Kermanshah University of Medical Sciences. The patients were from different cities of Kermanshah province. All the patients had the clinical signals and two positive sweat tests. After filling agreement forms and questionnaire, the peripheral blood sampling and DNA extraction were done. DNA samples were extracted. PCR and sequencing special PCR were done. Finally analysis of the results with DNA sequencing analysis version 5.2 software was performed. RESULTS: CFTR mutations analysis identified 4 different mutations in our CF patients. The disease-causing mutations were p.F508del (DeltaF508) (14.81%), p.S466X (1.85%), and p.T1036I (1.85%). M470V polymorphism with frequency of 74.1% was found in 23 patients (17 homozygous and 6 heterozygous). CONCLUSION: Three disease-causing mutations in CF patients in the present study account for approximately 18.51% of mutations. The frequency of p.F508del, the most common mutation was 16-18.1% in Iranian population. The results of the present study can be applied for genetic counseling, population screening and prenatal diagnosis.
Comments [show]
None has been submitted yet.
No. Sentence Comment
12 The disease-causing mutations were p.F508del (࢞F508) (14.81%), p.S466X (1.85%), and p.T1036I (1.85%).
X
ABCC7 p.Thr1036Ile 24696795:12:92
status: NEW17 Keywords: ࢞F508, Cystic fibrosis, Direct sequencing, Iran, Kermanshah, M470V, S466X, T1036I.
X
ABCC7 p.Thr1036Ile 24696795:17:91
status: NEW62 T1036I mutation (C to T at 3239) .
X
ABCC7 p.Thr1036Ile 24696795:62:0
status: NEW72 Genotype analysis: Mutation screening of CFTR gene in 54 alleles by sequencing reaction for all common mutations (exon 10 and exon 17a) showed that 10 alleles were ƊF508 (14.81%), S466X (1.85%) and T1036I (1.85%) and also showed 40 alleles (74.1%) with M470V polymorphism.
X
ABCC7 p.Thr1036Ile 24696795:72:203
status: NEW82 of Patients Global distribution Homozygote Heterozygote Exon 10 Deletion of CTT from 16533 p.F508del 1 6 Global Exon 10 C to G at 1529 p.S466X - 1 Germany-Iran Exon17a C to T at 3239 p.T1036I - 1 Iran Table 3.
X
ABCC7 p.Thr1036Ile 24696795:82:185
status: NEW83 Comparison of the frequency of common CFTR mutations (%) in the present study, west Asia, north Africa and Indian subcontinent Region or Country Frequency of CF alleles (%) F508del S466x T1036I This study 14.81 1.85 1.85 Lebanon 34-37 - - Palestine 23.5 - - Jordan 7.4-12 - - Syria 1 patient - - Saudi Arabia, United Arab Emirates, Oman, Qatar, Kuwait 12 - - Saudi Arabia 13-15 - - Algeria 16.7 - - Bahrain 7.7 - - Turkey 24-27 * - Pakistan 17-56 - - Tunisia 18 - - Indian 19-40 * - * Some reports about this mutation (S466X) in Italy's northeast, France's northwest, Turkey, Greece and India This is the first time that such a study is done for Kurdish people in Islamic Republic of Iran.
X
ABCC7 p.Thr1036Ile 24696795:83:187
status: NEW115 T1036I mutations: In exon 17a, T1036I mutation is reported as a heterozygote for the second time in the world.
X
ABCC7 p.Thr1036Ile 24696795:115:0
status: NEWX
ABCC7 p.Thr1036Ile 24696795:115:31
status: NEW120 The frequency of T1036I mutation (C to T at 3239) was 1.85% in this study and it was involved with just one patient (Figure1 and Table 2).
X
ABCC7 p.Thr1036Ile 24696795:120:17
status: NEW137 Conclusion Frequency of ƊF508, S466X and T1036I mutations in this study are quite comparable to similar studies in Iran and neighboring regions.
X
ABCC7 p.Thr1036Ile 24696795:137:46
status: NEW